Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?

被引：8
|
作者：
Gaffney, David K. [1 ]
机构：
[1] Univ Utah, Dept Radiat Oncol, Huntsman Canc Hosp, Salt Lake City, UT 84112 USA
来源：
JOURNAL OF GYNECOLOGIC ONCOLOGY | 2012年 / 23卷 / 04期
关键词：
UTERINE CERVIX; CARCINOMA; BRACHYTHERAPY; RADIOTHERAPY; SURVIVAL; IMPACT;
D O I：
10.3802/jgo.2012.23.4.207
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：207 / 209
页数：3
相关论文
共 50 条
  • [21] Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Kim, Young-Seok
    Kim, Ha Jeong
    Lee, Jeong-Won
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Huh, Seung Jae
    Nam, Joo-Hyun
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2012, 23 (04) : 226 - 234
  • [22] Comparison of survival outcomes between laparoscopic surgery and abdominal surgery for radical hysterectomy as primary treatment in patients with stage IB2/IIA2 cervical cancer
    Chen, Chunlin
    Guo, Jianxin
    Liu, Ping
    Li, Zhiqiang
    Jiang, Haixia
    Zhu, Qianyong
    Bin, Xiaonong
    Lang, Jinghe
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (04) : 1516 - 1526
  • [23] Association between Three Therapeutic Strategies and Clinical Outcomes of 2009 FIGO Stage IB2/IIA2 Cervical Cancer
    Zhang, Yong
    Tang, Xiaobi
    Ma, Shanshan
    Shen, Meizhu
    Jiang, Li
    Yuan, Wenchao
    Wang, Rensheng
    Wu, Fang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [24] Analysis of clinical and angiogenesis factors with cervical cancer stage IB2 And IIA2 neo-adjuvant chemotherapy responses
    Muhammad, Syamel
    Susanti, Restu
    Hidayat, Yudi Mulyana
    Muthmainnah, Diniy Miftahul
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A82 - A82
  • [25] CLINICAL APPLICATION VALUE OF CERVICAL CANCER RADICAL SURGERY PLUS VENTRAL PARA-AORTIC LYMPH NODE DISSECTION IN THE IB2 AND IIA2 CERVICAL CANCER TREATMENT
    Deng, Yun
    Xiao, Chuli
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (01) : 64 - 64
  • [26] Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: A comparison of complications for open versus minimally invasive surgery
    Miller, H.
    Hom, M. S.
    Castaneda, A.
    Matsuo, K.
    Roman, L. D.
    Brunette, L. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 202 - 202
  • [27] Clinico-pathological factors predicting parametrial invasion in IB2, IIA1, IIA2 (FIGO2009) cervical cancer
    Hsu, H. C.
    Cheng, W. F.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 199 - 199
  • [28] Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis
    Cheng, Jing
    Liu, Beibei
    Wang, Biao
    Long, Xicui
    Li, Zhihong
    Chen, Ruili
    Wu, Ruiting
    Xu, Lin
    BMC CANCER, 2021, 21 (01)
  • [29] Efficacy and prognostic factors of concurrent chemoradiotherapy in patients with stage Ib3 and IIa2 cervical cancer
    Liu, Tingting
    Kong, Weimin
    Liu, Yao
    Song, Dan
    GINEKOLOGIA POLSKA, 2020, 91 (02) : 57 - 61
  • [30] Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery
    Miller, Heather
    Matsuo, Koji M.
    Roman, Lynda D.
    Yessaian, Annie A.
    Pham, Huyen Q.
    Hom, Marianne
    Castaneda, Antonio
    Pham, Anthony
    Ragab, Omar
    Muderspach, Laila
    Ciccone, Marcia
    Brunette, Laurie L.
    RADIATION ONCOLOGY, 2021, 16 (01)
12345